ATE179889T1 - Arzneimittel, die ester omega-3 polyungesättigter säuren enthalten und deren verwendung in der topischen behandlung morbider erkrankungen - Google Patents
Arzneimittel, die ester omega-3 polyungesättigter säuren enthalten und deren verwendung in der topischen behandlung morbider erkrankungenInfo
- Publication number
- ATE179889T1 ATE179889T1 AT93110903T AT93110903T ATE179889T1 AT E179889 T1 ATE179889 T1 AT E179889T1 AT 93110903 T AT93110903 T AT 93110903T AT 93110903 T AT93110903 T AT 93110903T AT E179889 T1 ATE179889 T1 AT E179889T1
- Authority
- AT
- Austria
- Prior art keywords
- omega
- containing esters
- products containing
- polyunsaturated acids
- topical treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9201438A NL9201438A (nl) | 1992-08-11 | 1992-08-11 | Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE179889T1 true ATE179889T1 (de) | 1999-05-15 |
Family
ID=19861171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93110903T ATE179889T1 (de) | 1992-08-11 | 1993-07-08 | Arzneimittel, die ester omega-3 polyungesättigter säuren enthalten und deren verwendung in der topischen behandlung morbider erkrankungen |
Country Status (9)
Country | Link |
---|---|
US (1) | US5472705A (de) |
EP (1) | EP0582834B1 (de) |
JP (1) | JPH06157351A (de) |
KR (1) | KR940003551A (de) |
AT (1) | ATE179889T1 (de) |
CA (1) | CA2100692A1 (de) |
DE (1) | DE69324862D1 (de) |
NL (1) | NL9201438A (de) |
NO (1) | NO309363B1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19611953A1 (de) * | 1996-03-26 | 1997-10-02 | Beiersdorf Ag | Verwendung von ungesättigten Monocarbonsäuren gegen Superinfektionen |
WO1997038688A1 (en) * | 1996-04-12 | 1997-10-23 | Peptide Technology Pty. Limited | Methods of treating immunopathologies using polyunsaturated fattyacids |
EP0919230A1 (de) * | 1997-12-01 | 1999-06-02 | Societe Des Produits Nestle S.A. | Verwendung des nmifa als Entzündungshemmer in oberflächlichem Saugetier-Gewebe |
US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
TW200418957A (en) * | 2002-11-22 | 2004-10-01 | Nippon Suisan Kaiaha Ltd | Compositions for external use containing polyunsaturated fatty acids salts thereof or esters thereof and method of manufacturing the same |
GB0920846D0 (en) | 2009-11-27 | 2010-01-13 | Croda Int Plc | Defenin inducing agent |
EP3348262A1 (de) | 2012-01-06 | 2018-07-18 | Omthera Pharmaceuticals Inc. | Verfahren zur herstellung von dpa-angereicherten zusammensetzungen von mehrfach ungesättigten omega-3-fettsäuren in freier säureform |
EA038222B1 (ru) * | 2016-12-22 | 2021-07-26 | ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. | Композиция для ухода за кожей и ее применение |
EA038212B1 (ru) * | 2016-12-22 | 2021-07-23 | ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. | Композиция для ухода за кожей, способ ее получения и применение |
PL437191A1 (pl) | 2021-03-01 | 2022-09-05 | Ester Labs OÜ | Formulacja do stosowania zewnętrznego oraz jej zastosowanie |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1539270A (en) * | 1976-12-31 | 1979-01-31 | Evers & Co Fabrik | Therapeutic agent for the external treatment of psoriasis tinea and eczemas |
US4211793A (en) * | 1979-03-19 | 1980-07-08 | American Cyanamid Company | Triethyl citrate solutions of PGE-type compounds |
DE3002089A1 (de) * | 1980-01-22 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue, substituierte 1,8-dihydroxy-9-(10h)-anthracenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
GB2098065A (en) * | 1981-04-14 | 1982-11-17 | Nippon Suisan Kaisha Ltd | Antithrombotic compositions containing docosahexaenoic acid |
FR2548021B1 (fr) * | 1983-06-29 | 1986-02-28 | Dick P R | Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels |
US4515810A (en) * | 1983-10-06 | 1985-05-07 | American Cyanamid Company | Composition of matter |
JPH075450B2 (ja) * | 1987-09-04 | 1995-01-25 | 鐘紡株式会社 | 透明な液状の油性化粧料 |
GB2218904A (en) * | 1988-05-27 | 1989-11-29 | Renafield Limited | Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
DE3820693A1 (de) * | 1988-06-18 | 1989-12-21 | Henkel Kgaa | Topische kosmetische und pharmazeutische zubereitungen |
US5110814A (en) * | 1989-01-11 | 1992-05-05 | Asta Pharma Ag | Azelastine and its salts used to combat psoriasis |
JPH0390022A (ja) * | 1989-08-31 | 1991-04-16 | Mochida Pharmaceut Co Ltd | 皮膚疾患治療用外用剤 |
JPH0390046A (ja) * | 1989-08-31 | 1991-04-16 | Mochida Pharmaceut Co Ltd | エイコサペンタエン酸またはそのエステルを含有する安定化組成物 |
DE4022815A1 (de) * | 1990-07-18 | 1992-01-23 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen |
-
1992
- 1992-08-11 NL NL9201438A patent/NL9201438A/nl not_active Application Discontinuation
-
1993
- 1993-07-08 AT AT93110903T patent/ATE179889T1/de active
- 1993-07-08 EP EP93110903A patent/EP0582834B1/de not_active Expired - Lifetime
- 1993-07-08 DE DE69324862T patent/DE69324862D1/de not_active Expired - Lifetime
- 1993-07-16 CA CA002100692A patent/CA2100692A1/en not_active Abandoned
- 1993-07-23 US US08/096,007 patent/US5472705A/en not_active Expired - Lifetime
- 1993-08-10 NO NO932843A patent/NO309363B1/no not_active IP Right Cessation
- 1993-08-11 KR KR1019930015554A patent/KR940003551A/ko not_active IP Right Cessation
- 1993-08-11 JP JP5219182A patent/JPH06157351A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR940003551A (ko) | 1994-03-12 |
CA2100692A1 (en) | 1994-02-12 |
EP0582834B1 (de) | 1999-05-12 |
DE69324862D1 (de) | 1999-06-17 |
JPH06157351A (ja) | 1994-06-03 |
US5472705A (en) | 1995-12-05 |
NO309363B1 (no) | 2001-01-22 |
NO932843L (no) | 1994-02-14 |
NO932843D0 (no) | 1993-08-10 |
EP0582834A1 (de) | 1994-02-16 |
NL9201438A (nl) | 1994-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ295303A (en) | Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds | |
FI972621A (fi) | Ei-steroidisten tulehduksenvastaisten karboksyylihappojen estereitä ja amideja, joita voidaan käyttää antioksidantteina, 5-lipoksigenaasi-inhibiittoreina ja ei-steroidisina tulehduksenvastaisina tuotteina | |
IT1223290B (it) | Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche | |
ATE130758T1 (de) | Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten. | |
DE3382641D1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
DE3676645D1 (de) | 2-(2-fluor-4-biphenylyl)propionsaeure oder deren salze enthaltende arzneimittel. | |
KR910019638A (ko) | Tgf-베타 조성물 | |
RU94002337A (ru) | Фармацевтическая композиция, применение гамма-линоленовой или дигомо-гамма-линоленовой кислоты для лечения поражений после облучения, способ лечения | |
ATE138639T1 (de) | L-carnitin- und alkanoyl-l-carnitin-ester mit glykolsäure oder ihre ester und diese enthaltende pharmazeutische zusammensetzungen zur behandlung von dermatosen | |
ATE179889T1 (de) | Arzneimittel, die ester omega-3 polyungesättigter säuren enthalten und deren verwendung in der topischen behandlung morbider erkrankungen | |
US5246726A (en) | Iron-containing composition and method for treatment of cancer | |
AU595012B2 (en) | Iron - containing composition and method for treatment of cancer | |
DE60008127D1 (de) | Diät mit hohem lipidgehalt | |
AU554413B2 (en) | Linoleic acid and essential fatty acid compositions as | |
AU633618B2 (en) | Fatty acid therapy | |
CA1302892C (en) | Peptic ulcer composition containing essential fatty acids | |
SE8802243D0 (sv) | Farmaceutisk beredning |